55 results
Page 2 of 3
PRE 14A
gxra5jro
13 Apr 23
Preliminary proxy
4:30pm
8-K
EX-99.1
wg0xxz470egiz8l
10 Nov 22
Nuvalent Reviews Corporate and Pipeline Achievements and Reports Third Quarter 2022 Financial Results
6:37am
8-K
EX-99.1
5d594hrtiwtaf7uyq3e1
1 Nov 22
Nuvalent Announces Pricing of Public Offering of Common Stock
5:19pm
8-K
gnwzinhm
1 Nov 22
Nuvalent Announces Pricing of Public Offering of Common Stock
5:19pm
424B5
t9e7lo38 cnys1mxugfv
1 Nov 22
Prospectus supplement for primary offering
5:17pm
424B5
0ljg9k
31 Oct 22
Prospectus supplement for primary offering
7:21am
8-K
ga8hoobq43ojxk2d bc
28 Oct 22
Other Events
6:05am
8-K
EX-99.1
tt1a4f ywfzd9jx2
28 Oct 22
Other Events
6:05am
424B5
2ek8d8 f2uzq
17 Aug 22
Prospectus supplement for primary offering
4:23pm
S-3
l5cviywkc7lkhmvltkzc
10 Aug 22
Shelf registration
8:35am
8-K
EX-99.1
oaj08g56
10 Aug 22
Nuvalent Highlights Execution Across Pipeline of Novel Kinase Inhibitors and Reports Second Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
fb6ugi
12 May 22
Nuvalent Highlights Pipeline and Business Progress and Reports First Quarter 2022 Financial Results
6:45am
DEF 14A
zulpga 6dwag
29 Apr 22
Definitive proxy
4:07pm
10-K
qg6b8g
29 Mar 22
Annual report
7:21am
8-K
EX-99.1
cbe64mt7 uohv4h
29 Mar 22
Nuvalent Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
6:58am